Protein–protein interactions in human disease
|
journal
|
August 2005 |
Targeting protein–protein interactions as an anticancer strategy
|
journal
|
July 2013 |
Targeting protein–protein interactions for cancer therapy
|
journal
|
November 2005 |
Inhibitors of protein–protein interactions (PPIs): an analysis of scaffold choices and buried surface area
|
journal
|
June 2018 |
Small-Molecule Inhibitors of Protein-Protein Interactions: Progressing toward the Reality
|
journal
|
September 2014 |
Small molecules, big targets: drug discovery faces the protein–protein interaction challenge
|
journal
|
April 2016 |
Protein-protein interaction inhibitors: advances in anticancer drug design
|
journal
|
August 2016 |
Protein-protein interaction modulators: advances, successes and remaining challenges
|
journal
|
July 2019 |
Predicting druggable binding sites at the protein–protein interface
|
journal
|
February 2009 |
Between a rock and a hard place?
|
journal
|
March 2006 |
Reaching for high-hanging fruit in drug discovery at protein–protein interfaces
|
journal
|
December 2007 |
Protein-protein docking benchmark version 4.0: Protein-Protein Docking Benchmark Version 4.0
|
journal
|
July 2010 |
Inhibiting Protein-Protein Interactions as an Emerging Paradigm for Drug Discovery
|
journal
|
February 2007 |
Twenty years on: the impact of fragments on drug discovery
|
journal
|
July 2016 |
Druggability Indices for Protein Targets Derived from NMR-Based Screening Data
|
journal
|
April 2005 |
New Frontiers in Druggability
|
journal
|
August 2015 |
Permeability of lipid bilayers to water and ionic solutes
|
journal
|
June 1986 |
Molecular Properties That Influence the Oral Bioavailability of Drug Candidates
|
journal
|
June 2002 |
Discovery and Development of Kelch-like ECH-Associated Protein 1. Nuclear Factor Erythroid 2-Related Factor 2 (KEAP1:NRF2) Protein–Protein Interaction Inhibitors: Achievements, Challenges, and Future Directions
|
journal
|
October 2016 |
Small Molecule Modulators of Keap1-Nrf2-ARE Pathway as Potential Preventive and Therapeutic Agents: SMALL MOLECULE MODULATORS OF KEAP1-NRF2-ARE PATHWAY
|
journal
|
May 2012 |
Discovery of direct inhibitors of Keap1–Nrf2 protein–protein interaction as potential therapeutic and preventive agents
|
journal
|
July 2015 |
Keap1 Recruits Neh2 through Binding to ETGE and DLG Motifs: Characterization of the Two-Site Molecular Recognition Model
|
journal
|
April 2006 |
Structure of the Keap1:Nrf2 interface provides mechanistic insight into Nrf2 signaling
|
journal
|
August 2006 |
Different Electrostatic Potentials Define ETGE and DLG Motifs as Hinge and Latch in Oxidative Stress Response
|
journal
|
November 2007 |
Emerging roles of Nrf2 and phase II antioxidant enzymes in neuroprotection
|
journal
|
January 2013 |
Protection against electrophile and oxidant stress by induction of the phase 2 response: Fate of cysteines of the Keap1 sensor modified by inducers
|
journal
|
February 2004 |
An Nrf2/Small Maf Heterodimer Mediates the Induction of Phase II Detoxifying Enzyme Genes through Antioxidant Response Elements
|
journal
|
July 1997 |
The Nrf2-Antioxidant Response Element Signaling Pathway and Its Activation by Oxidative Stress
|
journal
|
May 2009 |
Keap1 Is a Redox-Regulated Substrate Adaptor Protein for a Cul3-Dependent Ubiquitin Ligase Complex
|
journal
|
December 2004 |
The Keap1-Nrf2 pathway: Mechanisms of activation and dysregulation in cancer
|
journal
|
January 2013 |
Molecular mechanisms of the Keap1-Nrf2 pathway in stress response and cancer evolution: Molecular mechanisms of the Keap1-Nrf2 pathway
|
journal
|
January 2011 |
Nrf2 protects against airway disorders
|
journal
|
April 2010 |
The Nrf2/ARE Pathway as a Potential Therapeutic Target in Neurodegenerative Disease
|
journal
|
March 2009 |
Targeting the Nrf2 pathway against cardiovascular disease
|
journal
|
June 2009 |
Association of Keap1 and Nrf2 Genetic Mutations and Polymorphisms With Endometrioid Endometrial Adenocarcinoma Survival
|
journal
|
January 2011 |
Nrf2 and Keap1 Abnormalities in Non–Small Cell Lung Carcinoma and Association with Clinicopathologic Features
|
journal
|
June 2010 |
Oncogenic NRF2 mutations in squamous cell carcinomas of oesophagus and skin: NRF2 in squamous cell carcinomas
|
journal
|
October 2009 |
High Levels of Nrf2 Determine Chemoresistance in Type II Endometrial Cancer
|
journal
|
June 2010 |
Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2
|
journal
|
April 2008 |
Genetic Alteration of Keap1 Confers Constitutive Nrf2 Activation and Resistance to Chemotherapy in Gallbladder Cancer
|
journal
|
October 2008 |
Dysfunctional KEAP1–NRF2 Interaction in Non-Small-Cell Lung Cancer
|
journal
|
October 2006 |
The emerging role of the Nrf2-Keap1 signaling pathway in cancer
|
journal
|
October 2013 |
Fumarates Promote Cytoprotection of Central Nervous System Cells against Oxidative Stress via the Nuclear Factor (Erythroid-Derived 2)-Like 2 Pathway
|
journal
|
January 2012 |
Dimethyl Fumarate and Monoethyl Fumarate Exhibit Differential Effects on KEAP1, NRF2 Activation, and Glutathione Depletion In Vitro
|
journal
|
March 2015 |
Structure–Activity and Structure–Property Relationship and Exploratory in Vivo Evaluation of the Nanomolar Keap1–Nrf2 Protein–Protein Interaction Inhibitor
|
journal
|
August 2015 |
Monoacidic Inhibitors of the Kelch-like ECH-Associated Protein 1: Nuclear Factor Erythroid 2-Related Factor 2 (KEAP1:NRF2) Protein–Protein Interaction with High Cell Potency Identified by Fragment-Based Discovery
|
journal
|
April 2016 |
A Comparative Assessment Study of Known Small-Molecule Keap1−Nrf2 Protein–Protein Interaction Inhibitors: Chemical Synthesis, Binding Properties, and Cellular Activity
|
journal
|
August 2019 |
Structure–Activity and Structure–Conformation Relationships of Aryl Propionic Acid Inhibitors of the Kelch-like ECH-Associated Protein 1/Nuclear Factor Erythroid 2-Related Factor 2 (KEAP1/NRF2) Protein–Protein Interaction
|
journal
|
April 2019 |
Binding Mode and Structure-Activity Relationships around Direct Inhibitors of the Nrf2-Keap1 Complex
|
journal
|
February 2014 |
Multiple binding modes of a small molecule to human Keap1 revealed by X-ray crystallography and molecular dynamics simulation
|
journal
|
January 2015 |
Probing the structural requirements of non-electrophilic naphthalene-based Nrf2 activators
|
journal
|
October 2015 |
Small molecules inhibit the interaction of Nrf2 and the Keap1 Kelch domain through a non-covalent mechanism
|
journal
|
July 2013 |
A hot spot of binding energy in a hormone-receptor interface
|
journal
|
January 1995 |
Hot-spot mimicry of a cytokine receptor by a small molecule
|
journal
|
October 2006 |
Hot spots-A review of the protein-protein interface determinant amino-acid residues
|
journal
|
June 2007 |
Anatomy of hot spots in protein interfaces
|
journal
|
July 1998 |
Predicting protein interaction sites: binding hot-spots in protein–protein and protein–ligand interfaces
|
journal
|
March 2006 |
Unraveling hot spots in binding interfaces: progress and challenges
|
journal
|
February 2002 |
Hot spots in protein–protein interfaces: Towards drug discovery
|
journal
|
November 2014 |
Peptide inhibitors of the Keap1–Nrf2 protein–protein interaction
|
journal
|
January 2012 |
A systematic molecular dynamics approach to the study of peptide Keap1–Nrf2 protein–protein interaction inhibitors and its application to p62 peptides
|
journal
|
January 2016 |
The rise of fragment-based drug discovery
|
journal
|
June 2009 |
A decade of fragment-based drug design: strategic advances and lessons learned
|
journal
|
February 2007 |
An Experimental Approach to Mapping the Binding Surfaces of Crystalline Proteins
|
journal
|
January 1996 |
Ligand deconstruction: Why some fragment binding positions are conserved and others are not
|
journal
|
April 2015 |
Lessons from Hot Spot Analysis for Fragment-Based Drug Discovery
|
journal
|
November 2015 |
The FTMap family of web servers for determining and characterizing ligand-binding hot spots of proteins
|
journal
|
April 2015 |
FTMAP: extended protein mapping with user-selected probe molecules
|
journal
|
May 2012 |
Comprehensive Experimental and Computational Analysis of Binding Energy Hot Spots at the NF-κB Essential Modulator/IKKβ Protein–Protein Interface
|
journal
|
April 2013 |
Relationship between Hot Spot Residues and Ligand Binding Hot Spots in Protein–Protein Interfaces
|
journal
|
July 2012 |
Fragment-based identification of druggable ‘hot spots’ of proteins using Fourier domain correlation techniques
|
journal
|
January 2009 |
Structural conservation of druggable hot spots in protein-protein interfaces
|
journal
|
August 2011 |
Crystal-contact engineering to obtain a crystal form of the Kelch domain of human Keap1 suitable for ligand-soaking experiments
|
journal
|
May 2013 |
Program DYNAFIT for the Analysis of Enzyme Kinetic Data: Application to HIV Proteinase
|
journal
|
June 1996 |
Interpreting Steep Dose-Response Curves in Early Inhibitor Discovery
|
journal
|
December 2006 |
A detergent-based assay for the detection of promiscuous inhibitors
|
journal
|
June 2006 |
Phaser crystallographic software
|
journal
|
July 2007 |
Features and development of Coot
|
journal
|
March 2010 |
Focused grid‐based resampling for protein docking and mapping
|
journal
|
February 2016 |
Analysis of Binding Site Hot Spots on the Surface of Ras GTPase
|
journal
|
November 2011 |
DRoP: A Water Analysis Program Identifies Ras-GTP-Specific Pathway of Communication between Membrane-Interacting Regions and the Active Site
|
journal
|
February 2014 |
Peptide segments in protein-protein interfaces
|
journal
|
January 2007 |
The atomic structure of protein-protein recognition sites 1 1Edited by A. R. Fersht
|
journal
|
February 1999 |
Structural and biochemical characterization of the KLHL3–WNK kinase interaction important in blood pressure regulation
|
journal
|
May 2014 |
Phosphorylation of p62 Activates the Keap1-Nrf2 Pathway during Selective Autophagy
|
journal
|
September 2013 |
Structural analysis of the complex of Keap1 with a prothymosin α peptide
- Padmanabhan, Balasundaram; Nakamura, Yoshihiro; Yokoyama, Shigeyuki
-
Acta Crystallographica Section F Structural Biology and Crystallization Communications, Vol. 64, Issue 4
https://doi.org/10.1107/S1744309108004995
|
journal
|
March 2008 |
Hot Spot Analysis for Driving the Development of Hits into Leads in Fragment-Based Drug Discovery
|
journal
|
December 2011 |
Crystal Structure of the Kelch Domain of Human Keap1
|
journal
|
December 2004 |
Binding of disordered proteins to a protein hub
|
journal
|
July 2013 |
Binding of Disordered Peptides to Kelch: Insights from Enhanced Sampling Simulations
|
journal
|
December 2015 |
High-resolution epitope mapping of hGH-receptor interactions by alanine-scanning mutagenesis
|
journal
|
June 1989 |
Optimization of Fluorescently Labeled Nrf2 Peptide Probes and the Development of a Fluorescence Polarization Assay for the Discovery of Inhibitors of Keap1-Nrf2 Interaction
|
journal
|
December 2011 |
Kinetic Analyses of Keap1-Nrf2 Interaction and Determination of the Minimal Nrf2 Peptide Sequence Required for Keap1 Binding Using Surface Plasmon Resonance: Kinetic Analyses of Keap1-Nrf2 Peptide Interactions
|
journal
|
October 2011 |
A General Framework for Development and Data Analysis of Competitive High-Throughput Screens for Small-Molecule Inhibitors of Protein−Protein Interactions by Fluorescence Polarization †
|
journal
|
December 2004 |
Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction
|
journal
|
December 1973 |
Modified Peptide Inhibitors of the Keap1–Nrf2 Protein–Protein Interaction Incorporating Unnatural Amino Acids
|
journal
|
July 2018 |
Evaluating the Catalytic Contribution from the Oxyanion Hole in Ketosteroid Isomerase
|
journal
|
December 2011 |
A ‘Rule of Three’ for fragment-based lead discovery?
|
journal
|
October 2003 |
High-throughput assays for promiscuous inhibitors
|
journal
|
July 2005 |
Molecular effects of cancer-associated somatic mutations on the structural and target recognition properties of Keap1
|
journal
|
March 2015 |
Oxidative Stress Sensor Keap1 Functions as an Adaptor for Cul3-Based E3 Ligase To Regulate Proteasomal Degradation of Nrf2
|
journal
|
July 2004 |
PGAM5 tethers a ternary complex containing Keap1 and Nrf2 to mitochondria
|
journal
|
May 2008 |
KEAP1 E3 Ligase-Mediated Downregulation of NF-κB Signaling by Targeting IKKβ
|
journal
|
October 2009 |
The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1
|
journal
|
February 2010 |
Exploring the structural origins of cryptic sites on proteins
|
journal
|
March 2018 |
Detection of secondary binding sites in proteins using fragment screening
|
journal
|
December 2015 |
ANCHOR: a web server and database for analysis of protein-protein interaction binding pockets for drug discovery
|
journal
|
June 2010 |
Superstar: improved knowledge-based interaction fields for protein binding sites11Edited by R. Huber
|
journal
|
March 2001 |